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Many patients with Crohn’s disease carry mutations
in NOD2, a molecule that can both activate and
attenuate the pro-inflammatory effects of NF-κB.
Recent studies implicate NOD2-induced ubiquitina-
tion of the NF-κB regulator NEMO as a potential
means of manipulating the NF-κB signal.
Crohn’s disease is a life-long, debilitating chronic
inflammatory condition of the gastrointestinal tract
that typically manifests during late childhood and ado-
lescence. A major breakthrough towards understand-
ing its pathophysiology came from the identification of
the gene encoding NOD2 (also known as CARD15) as
an important determinant of susceptibility. It is now
clear that NOD2 functions as an intracellular sensor of
bacteria, triggered specifically by a derivative of the
peptidoglycan layer of both Gram-negative and Gram-
positive bacteria called muramyl dipeptide (MDP) [1].
Recognition of MDP by NOD2 regulates the inflamma-
tory signaling cascade involving the transcription
factor NF-κB. Many Crohn’s disease patients carry
mutations in NOD2 that impair the detection of MDP,
resulting in an inability to activate NF-κB. New work of
Cantley and co-workers [2], published in this issue of
Current Biology, shows that the inability of mutant
NOD2 to ubiquitinate the NF-κB essential modulator
(NEMO/IKK-γ) may be at the hub of faulty NF-κB sig-
naling in Crohn’s disease.
Most of the Crohn’s disease-associated mutations
in NOD2 are predicted to alter the structure of the
MDP-sensing unit, a series of leucine-rich repeats at
the carboxyl terminus of NOD2 [3] (Figure 1). The con-
sequential inability to respond to MDP and activate
NF-κB in this inflammatory disorder was surprising,
considering that NF-κB is responsible for the induc-
tion of a large number of inflammatory mediators. A
defect in NF-κB activation should presumably result in
decreased inflammation and not the massive produc-
tion of cytokines that drive the inflammatory pathology
of Crohn’s disease. The NF-κB responses elicited by
MDP–NOD2 are therefore complex and of a pro- and
anti-inflammatory nature [4,5].
In order to try to understand more about this com-
plexity, we need to examine the activation of NF-κB,
which requires the IκB kinase (IKK) signalosome, a
protein complex composed of two kinase subunits
(IKK-α and IKK-β) and an essential non-catalytic
subunit, NEMO. As its name implies, the IKK signalo-
some is responsible for the phosphorylation of IκB
proteins, which normally sequester NF-κB in the cyto-
plasm. IκB phosphorylation triggers its ubiquitination
and ultimately its proteolytic degradation by the 26S
proteasome, freeing NF-κB to enter the nucleus and
activate transcription [6]. Despite the diversity of
signals and signaling cascades activating NF-κB, all
classical pathways induce the assembly and activa-
tion of the IKK signalosome. This pivotal position
demands that the IKK signalosome recognize and pre-
sumably integrate distinct signaling cascades. NEMO,
in particular its carboxyl terminus, is considered the
logical integrator/regulatory unit (Figure 2). While
NEMO is reported to bind to some signaling proteins,
the convergence of different signals at the IKK sig-
nalosome is, for the most part, unexplained [7].
Several stimuli have been shown to induce NEMO
ubiquitination [2,8–10] pointing to the use of this ubiq-
uitous and versatile protein modifier, ubiquitin, as an
attractive regulatory mechanism.
Ubiquitin is a reversible post-translational modifica-
tion with multiple ‘signals’ dictated by the topology in
which it is linked to a target protein. The 76 amino acid
ubiquitin molecule is conjugated on a lysine residue(s)
in the target protein either as a single moiety or as a
polypeptide chain, in which adjacent ubiquitin moi-
eties are linked to each other via one of potentially
seven different lysine residues within ubiquitin, most
commonly K48 or K63. The functional consequences
and importance of K48-linked ubiquitin in NF-κB acti-
vation are well established, as this results in targeted
degradation of conjugated proteins, such as IκB, by
the proteasome. Cantley and colleagues [2] now show
that MDP–NOD2 triggers the K63-linked polyubiquiti-
nation of NEMO but that this does not promote NEMO
degradation. Interestingly, Crohn’s disease mutants of
NOD2 are defective in MDP-triggered ubiquitination of
NEMO, suggesting that an active NOD2 signalosome
is required for NEMO ubiquitination. Indeed, RNAi
experiments demonstrated that RIP2, a scaffolding
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Figure 1. Domains and interactions of NOD2.
NOD2 consists of three distinct segments: two protein–protein
interaction domains called the caspase recruitment domain
(CARD), an ATP-dependent oligomerization unit (NOD and
NAD) and ten leucine rich repeats (LRRs). The scaffolding
kinase RIP2 contains a CARD that is recruited to NOD2 in an
MDP-dependent manner. Mutations in the LRR impair the
ability of NOD2 to sense MDP and are involved in susceptibility
to Crohn’s disease. finsC, frameshift mutation with C insertion.
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kinase essential for NF-κB activation downstream of
NOD2, is also essential for MDP–NOD2-triggered
NEMO ubiquitination. Moreover, their experiments
suggest that K63-linked ubiquitination of NEMO is
dependent on the recruitment of RIP2 to NOD2, which
is not recruited to the Crohn’s disease NOD2 mutants. 
The functional significance of this becomes appar-
ent by considering that K63-linked ubiquitin chains are
also appended to several inflammatory signaling mol-
ecules — such as TRAF2, TRAF6, RIP1 — that are
important for the activation of their respective NF-κB
signaling cascades [11]. K63-linked ubiquitination of
these proteins leads to the formation of ubiquitin-
dependent protein complexes via the ubiquitin-
binding proteins, TAB2 and TAB3 [12]. TAB2, for
example, binds the K63-linked chains on TRAF6
inducing the formation of a ubiquitin-dependent
complex that leads to the activation of TAK1, an IKK-
β kinase. Conveniently, ubiquitin-binding proteins are
themselves often ubiquitinated, which may in turn
create a network of ubiquitin-dependent interactions.
The formation of such a network could provide a
simple mechanism by which ubiquitinated NEMO
could be incorporated into diverse signaling com-
plexes and establish a means of activating the IKK
signalosome by recruiting its regulators or inducing a
conformational change leading to activation of IKK-β
by transphosphorylation. Conversely, destruction of
ubiquitin-dependent interactions could provide a
straightforward means of limiting the intensity and/or
inhibiting a given signaling cascade. In support of this
idea, two potent negative regulators of NF-κB, the
tumor suppressor gene product CYLD and A20, turn
out to be deubiquitinating enzymes that specifically
remove K63-linked polyubiquitin chains [13,14].
Several other stimuli are now also known to induce
NEMO ubiquitination, including TNFα, T-cell receptor
(TCR) signaling, and genotoxic stress. Consistent with
a fundamental role in IKK signalosome activation via
these stimuli, NEMO ubiquitination is necessary for full
NF-κB activity. In the case of TCR-induced ubiquitina-
tion, which was also demonstrated to trigger K63-
linked chains on NEMO, oligomerization of key
signaling proteins (Bcl10–paracaspase/MALT1–TRAF6)
leads to the assembly of a ubiquitin ligase complex
that specifically targets K399 of NEMO [8,15]. Interest-
ingly, although NOD2–RIP2-triggered ubiquitination of
NEMO may also occur at this site, NOD–RIP2 triggers
K63-linked ubiquitination at K285 of NEMO (Figure 2).
A precedent for diversity within the ubiquitination
profile of NEMO already exists, given that TNFα trig-
gers K6-linked (not K63-linked) ubiquitin on NEMO [9],
and DNA-damage-induced ubiquitination of NEMO
requires that the selected lysines, in this case 277 and
309, are first conjugated by the small ubiquitin-like
modifier SUMO prior to ubiquitination [10]. These find-
ings point to the intriguing possibility that specific
ubiquitin profiles on NEMO may integrate various
responses, orchestrating a specific repertoire of gene
activation. Given the recent finding that NOD2 nega-
tively regulates the inflammatory responses of the Toll-
like receptor 2 pathway, it will be interesting to test the
role of NEMO ubiquitination at K285 in this context [5]. 
From the recent work of Cantley and colleagues [2]
and other groups, several generalizations can be
drawn. Firstly, the use of networks of ubiquitin-binding
and ubiquitinated proteins culminating at ubiquiti-
nated NEMO may be a common mechanism in diverse
signaling cascades for activation of the IKK signalo-
some. It seems likely that other NF-κB signaling pro-
teins and other ubiquitin-binding proteins will be
uncovered. Secondly, localized regions of these ubiq-
uitin networks will inevitably be destroyed, at least
during normal transient responses to a stimulus,
through the action of deubiquitinating enzymes like
A20 and CYLD. Interestingly, some pathogenic bacte-
ria contain proteases that may be involved in the
removal of ubiquitin or ubiquitin-like molecules [16],
raising the question of whether bacteria, which are
known to contribute to the development of Crohn’s
disease, do so by exploiting ubiquitin networks.
Further work delineating the mechanism and specific
function of NOD2–RIP2-induced ubiquitination of
NEMO at K285 is likely to increase our understanding
of the role of NEMO in the NF-κB response and possi-
bly point to how deregulation of this particular
pathway may be involved in Crohn’s disease and
other autoinflammatory disorders.
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Figure 2. Sites of NEMO ubiquitination in response to various
stimuli.
NEMO is composed of multiple distinct domains, including a
coil-coiled domain (CC), a leucine zipper region (LZ) and a zinc
finger domain (ZF). MDP via NOD2–RIP2 triggers K63-linked
ubiquitination at K285 and possibly also at K399. T-cell recep-
tor (TCR) signaling, mimicked by Bcl10 overexpression specif-
ically triggers K63-linked ubiquitination at K399. TNFα via
c-IAP1 triggers K6-linked ubiquitination of NEMO. The zinc
finger is essential for TNFα-induced ubiquitination of NEMO
suggesting that K399, the only lysine in this region, is conju-
gated or that the zinc finger is required for recruitment of the
ubiquitin-conjugating machinery. Genotoxic stress first triggers
sumolyation of NEMO in a zinc-finger-dependent manner fol-
lowed by ubiquitination of unknown topology at K277/K309.
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